Click here to see an annotated bibliography of the data in the table.
This is a table of authors, titles, dates and other bibliographic information; it is a list metadata describing the content of your study carrel. Think of it as your library.
id | author | title | date | words | sentences | text |
---|---|---|---|---|---|---|
cord-279841-oq25o4qr | Ahlquist, Paul | Viral and host determinants of RNA virus vector replication and expression | 2005-03-07 | nan | nan | view text |
cord-282314-9cua2jzg | Albanese, Grace A. | Biological and molecular characterization of ArkGA: A novel Arkansas serotype vaccine that is highly attenuated, efficacious, and protective against homologous challenge | 2018-10-01 | 6368.0 | 324.0 | view text |
cord-262542-vevsgkp6 | Alharbi, Naif Khalaf | ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice | 2017-06-27 | 4923.0 | 244.0 | view text |
cord-279985-de0b27nq | Anraku, Itaru | Kunjin replicon-based simian immunodeficiency virus gag vaccines | 2008-06-19 | 6392.0 | 325.0 | view text |
cord-348218-wyy4rvqb | Ashwell, Douglas | When being positive might be negative: An analysis of Australian and New Zealand newspaper framing of vaccination post Australia's No Jab No Pay legislation | 2020-07-09 | nan | nan | view text |
cord-341626-04svm6le | Assink, M.D.M. | Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination | 2009-02-11 | nan | nan | view text |
cord-295191-xu26mvc3 | Avirutnan, Panisadee | Complement and its role in protection and pathogenesis of flavivirus infections | 2008-12-30 | nan | nan | view text |
cord-010279-ytnv0map | Bahnemann, Hans G. | Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine | 2002-11-12 | 3479.0 | 198.0 | view text |
cord-253477-gptjqti7 | Ball, Christopher | Comparative protective immunity provided by live vaccines of Newcastle disease virus or avian metapneumovirus when co-administered alongside classical and variant strains of infectious bronchitis virus in day-old broiler chicks | 2019-12-10 | 6863.0 | 371.0 | view text |
cord-322505-6q92742u | Basinski, Andrew J. | Evaluating the promise of recombinant transmissible vaccines | 2017-12-24 | 4188.0 | 174.0 | view text |
cord-345191-nabxpyw3 | Bell, Sadie | Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England | 2020-10-19 | nan | nan | view text |
cord-281635-a6ia8kxf | Bellinzoni, R. C. | Efficacy of an inactivated oil-adjuvanted rotavirus vaccine in the control of calf diarrhoea in beef herds in Argentina | 1989-06-30 | 3725.0 | 166.0 | view text |
cord-255026-fdp6mies | Belák, Sándor | Molecular diagnosis of viral diseases, present trends and future aspects: A view from the OIE Collaborating Centre for the Application of Polymerase Chain Reaction Methods for Diagnosis of Viral Diseases in Veterinary Medicine | 2007-07-26 | 5342.0 | 225.0 | view text |
cord-298551-ua90xoak | Bennet, Rutger | Influenza epidemiology among hospitalized children in Stockholm, Sweden 1998–2014 | 2016-06-14 | 3109.0 | 163.0 | view text |
cord-269448-1jikrn37 | Borja-Cabrera, G.P. | Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil | 2008-09-15 | 4941.0 | 231.0 | view text |
cord-273526-ah0dvnxv | Cao, Weiping | Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice | 2017-06-05 | 4390.0 | 222.0 | view text |
cord-342405-nsj9dh48 | Chakraborty, Chiranjib | India’s cost-effective COVID-19 vaccine development initiatives | 2020-10-20 | 522.0 | 38.0 | view text |
cord-282764-d9x1wii6 | Chang, Chia-Yin | Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development | 2006-02-20 | 4812.0 | 231.0 | view text |
cord-346032-188gnf8j | Cheung, Ying-Kit | Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope | 2007-08-10 | 4754.0 | 228.0 | view text |
cord-259299-z3o4t7mz | Chinsangaram, Jarasvech | Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus | 1998-10-31 | 3280.0 | 163.0 | view text |
cord-349309-7xsbpid7 | Condit, Richard C | The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines | 2020-09-06 | nan | nan | view text |
cord-261274-y74smbtd | Crouch, C. F | Lactogenic immunity following vaccination of cattle with bovine coronavirus | 2000-09-15 | nan | nan | view text |
cord-290783-ipoelk4h | Crouch, C. F. | Vaccination against enteric rota and coronaviruses in cattle and pigs: Enhancement of lactogenic immunity | 1985-09-30 | 4545.0 | 254.0 | view text |
cord-285128-48l1w65p | Custers, Jerome | Vaccines based on replication incompetent Ad26 viral vectors: standardized template with key considerations for a risk/benefit assessment | 2020-10-03 | 4728.0 | 295.0 | view text |
cord-271514-sls3bsm0 | Dean, Natalie E. | Ensemble Forecast Modeling for the Design of COVID-19 Vaccine Efficacy Trials | 2020-09-15 | nan | nan | view text |
cord-303200-hwvkvdlk | Decaro, Nicola | Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: A clinical and laboratory diagnostic dilemma | 2007-01-26 | nan | nan | view text |
cord-328698-eeg1k5a6 | Detoc, Maëlle | Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic | 2020-09-17 | 2522.0 | 129.0 | view text |
cord-324911-6s7ubbxl | Drury, Georgina | Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats | 2019-04-17 | nan | nan | view text |
cord-281676-yy5etfek | Dwivedi, Varun | Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant | 2011-05-23 | 5960.0 | 288.0 | view text |
cord-340686-uq0fsqh3 | Dwivedi, Varun | Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs | 2011-05-23 | 6474.0 | 333.0 | view text |
cord-260667-5aurua6o | Falchieri, Marco | Avian metapneumoviruses expressing Infectious Bronchitis virus genes are stable and induce protection | 2013-05-24 | nan | nan | view text |
cord-267712-mhx8e5y0 | Fang, Xinkui | Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors | 2012-02-08 | 5776.0 | 308.0 | view text |
cord-336730-hqgwj8vs | Fehr, Daniela | Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions | 1997-07-31 | nan | nan | view text |
cord-299952-xvtt8fz8 | Gao, LuLu | A randomized controlled trial of low-dose recombinant human interferons α-2b nasal spray to prevent acute viral respiratory infections in military recruits | 2010-06-17 | 4447.0 | 224.0 | view text |
cord-293360-nmttgxlq | García, Leidy Y. | Acceptance of a COVID-19 vaccine: A multifactorial consideration | 2020-11-10 | 519.0 | 35.0 | view text |
cord-323540-7b2mt1a8 | García, Leidy Y. | Contingent assessment of the COVID-19 vaccine | 2020-06-25 | 4014.0 | 180.0 | view text |
cord-296469-h0ma163u | Gellin, Bruce G. | Preparing for the unpredictable: The continuing need for pandemic influenza preparedness | 2016-10-26 | 1501.0 | 78.0 | view text |
cord-276907-b855tj7x | Giersing, Birgitte K. | Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016 | 2019-11-28 | 12249.0 | 457.0 | view text |
cord-273065-peqz7okh | Girard, Marc | Arboviruses: A global public health threat | 2020-04-24 | 5574.0 | 241.0 | view text |
cord-263443-m98qisld | Goldman, Ran D. | Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey | 2020-10-10 | 1033.0 | 75.0 | view text |
cord-255625-4r6ng57a | Graffigna, Guendalina | “Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy | 2020-11-10 | nan | nan | view text |
cord-254620-xcblqg4z | Harmon, Shawn H.E. | Immunization governance: Mandatory immunization in 28 Global NITAG Network countries() | 2020-09-26 | 5811.0 | 309.0 | view text |
cord-277355-si3g5dih | He, Yu | The role of capsid in the flaviviral life cycle and perspectives for vaccine development | 2020-09-17 | 6885.0 | 319.0 | view text |
cord-257533-i85dyg8n | Henn, Wolfram | Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity | 2020-06-23 | 1070.0 | 60.0 | view text |
cord-304807-j2k1oel2 | Herrera-Rodriguez, José | Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production | 2019-03-14 | nan | nan | view text |
cord-344316-mwnnmwnw | Herst, C.V. | An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design | 2020-04-28 | nan | nan | view text |
cord-341970-pho6dksc | Huang, Jun | Immunization with SARS-CoV S DNA vaccine generates memory CD4(+) and CD8(+) T cell immune responses | 2006-06-05 | nan | nan | view text |
cord-331900-xtwqv4fk | Hussain, Althaf I. | Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells() | 2010-05-14 | nan | nan | view text |
cord-288938-4bheqtk5 | Hönemann, M. | Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features | 2019-10-08 | 3189.0 | 206.0 | view text |
cord-276009-p98wjtjb | Iyer, Arun V. | Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01 | 2009-02-05 | 7538.0 | 406.0 | view text |
cord-291510-jh2fdks4 | Jiang, Yi | Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity | 2020-02-11 | 7943.0 | 403.0 | view text |
cord-277054-eq4obbte | Kaur, Manpreet | Rabies DNA vaccine: No impact of MHC Class I and Class II targeting sequences on immune response and protection against lethal challenge | 2009-03-26 | nan | nan | view text |
cord-313911-lfn9ggg3 | Kenner, Julie | LC16m8: An attenuated smallpox vaccine | 2006-11-17 | 7952.0 | 377.0 | view text |
cord-312517-b24zlaqt | Kim, Denny | The Brighton collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines | 2020-06-19 | 1948.0 | 98.0 | view text |
cord-007440-7gcpk9x9 | Koprowski, Hilary | Vaccines and sera through plant biotechnology() | 2005-03-07 | 2110.0 | 129.0 | view text |
cord-288309-6pw7t512 | Kusters, J. G. | Sequence evidence for RNA recombination in field isolates of avian coronavirus infectious bronchitis virus | 1990-12-31 | 1972.0 | 164.0 | view text |
cord-274765-3wzht843 | Kweon, Chang-Hee | Derivation of attenuated porcine epidemic diarrhea virus (PEDV) as vaccine candidate | 1999-06-04 | 2518.0 | 133.0 | view text |
cord-297022-zs5m36cp | Kwong, Jeffrey C. | Appropriate measures of influenza immunization program effectiveness | 2007-01-22 | 911.0 | 42.0 | view text |
cord-294856-eeh2a0t8 | Lambert, Paul-Henri | Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines | 2020-05-25 | 5236.0 | 251.0 | view text |
cord-332358-0t4uxmj2 | Lamphear, Barry J. | A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine | 2004-06-23 | 3131.0 | 136.0 | view text |
cord-292528-8kdhf123 | Lau, Yuk-Fai | A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic | 2009-02-25 | 6897.0 | 342.0 | view text |
cord-270910-xb746mv5 | Lebrun-Harris, Lydie A. | Influenza vaccination among U.S. pediatric patients receiving care from federally funded health centers | 2020-07-24 | nan | nan | view text |
cord-279364-j93f6eso | Liao, Qiuyan | What influenza vaccination programmes are preferred by healthcare personnel? A discrete choice experiment | 2020-05-07 | 4838.0 | 219.0 | view text |
cord-266745-jit1xeqc | Liou, Jenn-Fa | Passive protection effect of chicken egg yolk immunoglobulins on enterovirus 71 infected mice | 2010-11-29 | 5708.0 | 272.0 | view text |
cord-262940-eyejnexx | Liu, Genmei | Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins | 2013-11-12 | 3853.0 | 175.0 | view text |
cord-260145-grz0fe9l | Liu, Shengwang | Altered pathogenicity, immunogenicity, tissue tropism and 3′-7 kb region sequence of an avian infectious bronchitis coronavirus strain after serial passage in embryos | 2009-07-23 | 7486.0 | 366.0 | view text |
cord-272292-k0ugjb6f | Liu, Shih-Jen | Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates | 2006-04-12 | 4957.0 | 261.0 | view text |
cord-258902-h0wrs01h | Liu, Xianglei | Enhanced Elicitation of Potent Neutralizing Antibodies by the SARS-CoV-2 Spike Receptor Binding Domain Fc Fusion Protein in Mice | 2020-09-22 | 5015.0 | 268.0 | view text |
cord-284882-8vil7k5l | MacDonald, Angus J. | rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens | 2005-05-16 | 3922.0 | 206.0 | view text |
cord-316839-wckqscvm | Maunsell, Fiona P. | Field evaluation of a Mycoplasma bovis bacterin in young dairy calves | 2009-05-11 | 7396.0 | 342.0 | view text |
cord-256784-wfaqim7d | Modjarrad, Kayvon | MERS-CoV vaccine candidates in development: The current landscape | 2016-06-03 | 3335.0 | 153.0 | view text |
cord-302222-9ad0fw6z | Monath, Thomas P. | Vaccines against diseases transmitted from animals to humans: A one health paradigm | 2013-11-04 | 15722.0 | 669.0 | view text |
cord-330406-a1tvcgqj | Moore, George E. | A space–time cluster of adverse events associated with canine rabies vaccine | 2005-12-01 | 3220.0 | 157.0 | view text |
cord-301601-4vkag60z | Nakayama, Tetsuo | Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens | 2016-01-04 | 2950.0 | 160.0 | view text |
cord-318407-uy0f7f2o | Nara, Peter L. | Perspectives on advancing preventative medicine through vaccinology at the comparative veterinary, human and conservation medicine interface: Not missing the opportunities | 2008-11-18 | 12527.0 | 501.0 | view text |
cord-260334-xo8ruswo | New, R.R.C. | Antibody-mediated protection against MERS-CoV in the murine model() | 2019-07-09 | 5748.0 | 247.0 | view text |
cord-257792-m7nij17v | Ng, Oi-Wing | Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection | 2016-04-12 | 4237.0 | 203.0 | view text |
cord-315437-h6xjudm0 | Nyon, Mun Peak | Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen | 2018-03-27 | nan | nan | view text |
cord-303056-bdse9o26 | Okada, Masaji | Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models | 2007-04-20 | nan | nan | view text |
cord-274110-nyyunoha | Orlinger, Klaus K. | An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system | 2010-04-26 | 5113.0 | 271.0 | view text |
cord-252856-oc0zd11h | Pagliusi, Sonia | Quality vaccines for all people(): Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers'' Network, 05–07th October 2015, Bangkok, Thailand | 2016-06-30 | 4469.0 | 223.0 | view text |
cord-255549-i2o6rs29 | Pagliusi, Sonia | Vaccines: Shaping global health() | 2017-03-14 | 4357.0 | 255.0 | view text |
cord-271076-436nxsua | Paul-Pierre, Pastoret | Emerging diseases, zoonoses and vaccines to control them | 2009-10-30 | 3723.0 | 173.0 | view text |
cord-266204-ipa017wz | Poland, G. A. | Personalized vaccinology: A review | 2018-08-28 | 7232.0 | 331.0 | view text |
cord-276209-5999g9gp | Poland, Gregory A. | Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development | 2020-06-02 | 1607.0 | 105.0 | view text |
cord-271153-c0aw6jkz | Privor-Dumm, Lois | Archetype analysis of older adult immunization decision-making and implementation in 34 countries | 2020-05-27 | 7745.0 | 404.0 | view text |
cord-293234-ouykx6g5 | Puig-Barberà, J. | Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study | 2012-08-24 | 4417.0 | 226.0 | view text |
cord-309999-izdl0f2i | Qin, Ede | Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine | 2006-02-13 | 3944.0 | 205.0 | view text |
cord-302265-97sxlkjp | Ramasamy, R. | Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations | 2006-05-01 | 5386.0 | 267.0 | view text |
cord-253656-2x4y403o | Ren, Wenlin | Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates | 2020-06-24 | 3645.0 | 202.0 | view text |
cord-321901-zpi7uis1 | Roberts, Anjeanette | Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK | 2006-11-30 | 6600.0 | 311.0 | view text |
cord-294302-hboc3xcz | Roncati, Luca | COVID-19 vaccine and boosted immunity: nothing ad interim to do? | 2020-10-09 | nan | nan | view text |
cord-316295-x636ux34 | Roth, Bernhard | Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses | 2012-01-11 | 4140.0 | 190.0 | view text |
cord-263862-zzys31e9 | Ryan, Elizabeth J. | The Canarypox-virus vaccine vector ALVAC triggers the release of IFN-γ by Natural Killer (NK) cells enhancing Th1 polarization | 2007-04-30 | 5843.0 | 318.0 | view text |
cord-260761-ngms51ie | Sawada, Akihito | AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats | 2011-02-04 | 6575.0 | 321.0 | view text |
cord-294789-07hto8qn | Schoch-Spana, Monica | The public’s role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States | 2020-10-29 | nan | nan | view text |
cord-299323-riotkgj4 | Seo, Yurim | Elements of Regulatory Dissonance: Examining FDA and EMA Product Labeling of New Vaccines (2006–2018) | 2020-10-13 | 3649.0 | 196.0 | view text |
cord-010266-elhgew3x | Spier, R.E. | Ethical aspects of vaccines and vaccination | 1998-12-02 | 5153.0 | 207.0 | view text |
cord-252293-8286lsof | Suzuki, Motoi | Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan | 2018-05-17 | nan | nan | view text |
cord-285613-hbd44euq | Søborg, Christian | Vaccines in a hurry | 2009-05-26 | 3804.0 | 161.0 | view text |
cord-278598-3utk3k6z | Tarpey, I. | Safety and efficacy of an infectious bronchitis virus used for chicken embryo vaccination | 2006-11-17 | 4808.0 | 246.0 | view text |
cord-255734-038xu4hq | Taylor, Deborah R. | Obstacles and advances in SARS vaccine development | 2006-02-13 | 5334.0 | 263.0 | view text |
cord-288038-jdinf8od | Thindwa, Deus | Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality | 2020-06-19 | 2601.0 | 119.0 | view text |
cord-265757-8ces57rn | Tondella, M. L. | International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007 | 2009-02-05 | 11130.0 | 494.0 | view text |
cord-271650-biq0chyn | Torres, Juan M | Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease | 2000-09-15 | 4589.0 | 226.0 | view text |
cord-289090-7x2752j4 | Vergison, Anne | Microbiology of otitis media: A moving target | 2008-12-23 | 3443.0 | 174.0 | view text |
cord-271734-1cfhjuxi | Vergkizi, Souzan | Bacillus Calmette–Guérin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally | 2020-10-16 | nan | nan | view text |
cord-345658-u9vgycib | Volkmann, Ariane | The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform | 2020-10-17 | nan | nan | view text |
cord-268369-yj7m0n0f | Wang, Keyang | Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine | 2006-03-15 | 5703.0 | 306.0 | view text |
cord-325998-87l6nixc | Wong, J.P. | Activation of toll-like receptor signaling pathway for protection against influenza virus infection | 2009-05-26 | 2215.0 | 121.0 | view text |
cord-275337-c3qr15es | Wright, Edward | A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa | 2009-11-27 | 5845.0 | 283.0 | view text |
cord-307939-rydgncys | Wu, Shuangsheng | Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China | 2018-01-25 | 3759.0 | 192.0 | view text |
cord-342831-4qfe8kok | Xia, Yufei | Chitosan-based mucosal adjuvants: Sunrise on the ocean | 2015-11-04 | nan | nan | view text |
cord-339070-jnmogy7s | Yang, Lin | Influenza associated mortality in the subtropics and tropics: Results from three Asian cities | 2011-11-08 | 3599.0 | 162.0 | view text |
cord-282158-08u3x1z4 | Yang, William H. | Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial() | 2013-09-13 | 5295.0 | 252.0 | view text |
cord-283475-28900qlr | Yu, Wenzhou | Vaccine-preventable disease control in the People’s Republic of China: 1949–2016 | 2018-12-18 | 5046.0 | 203.0 | view text |
cord-275635-d50bxe7c | Yuan, Xiaomin | Efficacy and immunogenicity of recombinant swinepox virus expressing the A epitope of the TGEV S protein | 2015-07-31 | 3979.0 | 212.0 | view text |
cord-310249-cvv77f10 | Yule, Terecita D. | Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease | 1997-05-31 | 4606.0 | 247.0 | view text |
cord-295850-nb6miso7 | Zhang, Chuan-hai | Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain | 2005-05-02 | 2930.0 | 161.0 | view text |
cord-317347-by8albr9 | van Ginkel, Frederik W. | Age-dependent immune responses and immune protection after avian coronavirus vaccination | 2015-05-28 | 5792.0 | 288.0 | view text |
cord-354818-yf5lvbs1 | von Linstow, Marie-Louise | Self-reported immunity and opinions on vaccination of hospital personnel among paediatric healthcare workers in Denmark | 2020-08-13 | nan | nan | view text |